The forecast for scientific publications in drug discovery in Canada indicates a gradual decline from 2024 to 2028, starting from 82.68 publications and decreasing to 77.9 publications. This translates to a steady year-on-year decrease of approximately 1.5%. The compounded annual growth rate (CAGR) over this five-year period reflects an average yearly decline, underscoring a consistent downtrend.
Future trends to watch for include potential shifts in government funding policies, advancements in technology, and strategic collaborations between academic institutions and the pharmaceutical industry. These factors could significantly influence the research landscape and publication rates in drug discovery in Canada.
